• 1
    Di Bisceglie AM. Malignant tumors of the liver. In: SchiffER, SorrellMF, MaddreyWC, eds. Schiff's Diseases of the Liver. 8th Ed. Philadelphia: Lippincott-Raven 1999;12811304.
  • 2
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745750.MEDLINE
  • 3
    Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997; 25:259262.MEDLINE
  • 4
    Surveillance, Epidemiology, and End Results (SEER) Program Public-Use CD-ROM (1973–1996), National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch, released April 1999, based on August 1998 Submission.
  • 5
    World Health Organization. International Classification of Diseases for Oncology. Geneva, Switzerland: World Health Organization; 1976.
  • 6
    Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6:101121.
  • 7
    Truman BI, Teutch SM. Screening in the community. In: BrownsonRC, PetittiDB, eds. Applied Epidemiology. New York: Oxford University Press, 1998;223248.
  • 8
    Yoshida H, Shiratori Y, Moriyama M, Arakwa Y, Ide T, Sata M, Inoue O, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999; 131:174181.MEDLINE
  • 9
    Idhe DC, Sherlock P, Winawer SJ, Fortner JG. Clinical manifestations of hepatoma: a review of 6 years' experience at a cancer hospital. Am J Med 1974; 56:8391.MEDLINE
  • 10
    Chlebowski RT, Tong M, Weissman J, Block JB, Ramming KP, Weiner JM, Bateman JR, et al. Hepatocellular carcinoma: diagnostic and prognostic features in North American patients. Cancer 1984; 53:27012706.MEDLINE
  • 11
    Faivre J, Forman D, Estève J, Obradovic M, Sant M and the EUROCARE Working Group. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer 1998; 34:21842190.
  • 12
    Osaka Cancer Registry. Survival of cancer patients in Osaka, 1975–89. Osaka, 1998.
  • 13
    Landis S, Murray T, Bolden S, Wingo P. Cancer Statistics, 1998. CA Cancer J Clin 1998; 48:629.MEDLINE